| 000 | 01673 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517062833.0 | ||
| 264 | 0 | _c20161213 | |
| 008 | 201612s 0 0 eng d | ||
| 022 | _a1744-8409 | ||
| 024 | 7 |
_a10.1586/1744666X.2016.1117941 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCaso, Francesco | |
| 245 | 0 | 0 |
_aProgress in understanding and utilizing TNF-α inhibition for the treatment of psoriatic arthritis. _h[electronic resource] |
| 260 |
_bExpert review of clinical immunology _c2016 |
||
| 300 |
_a315-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Neutralizing _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Psoriatic _ximmunology |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSkin _xdrug effects |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aLubrano, Ennio | |
| 700 | 1 | _aDel Puente, Antonio | |
| 700 | 1 | _aCaso, Paolo | |
| 700 | 1 | _aPeluso, Rosario | |
| 700 | 1 | _aFoglia, Francesca | |
| 700 | 1 | _aBenigno, Carolina | |
| 700 | 1 | _aGirolimetto, Nicolò | |
| 700 | 1 | _aBottiglieri, Paolo | |
| 700 | 1 | _aScarpa, Raffaele | |
| 700 | 1 | _aCosta, Luisa | |
| 773 | 0 |
_tExpert review of clinical immunology _gvol. 12 _gno. 3 _gp. 315-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1586/1744666X.2016.1117941 _zAvailable from publisher's website |
| 999 |
_c25439783 _d25439783 |
||